Quince Therapeutics advances Ataxia-Telangiectasia treatment with innovative AIDE platform, insider support, and NEAT Phase 3 ...

The Phase 2 study of oral, once-daily mavorixafor was a six-month, open-label clinical trial that enrolled a total of 23 ...

With the digital asset market growing increasingly sophisticated, the noise can feel overwhelming. Between meme rallies, ...

Many taxpayers could see even more money in their pockets in coming years under a sweeping tax and spending cuts package that ...

Led by Rep. Jen Kiggans (R-Va.), the Republicans said the tax bill included some “reasonable phase-out schedules” but that ...

Q1 2025 Management View Rick Pauls, President and CEO, stated that "we continue to make substantial progress in both of our ...

We believe that Merck KGaA enjoys a narrow moat, driven by intangible assets and switching costs which are prevalent in its Life Science and Electronics businesses. A few acquisitions to fill gaps in ...

As of March 31, 2025, the Company's cash, cash equivalents and investments was $314.2 million. The Company expects that its ...

Energy Transfer ( ET 0.83%) pays a prodigious cash distribution to its investors. The master limited partnership's ( MLP) payout is currently around 7.3%. That's several times higher than the S&P ...

ZoomInfo Technologies upgraded to Buy amid improved fundamentals, rising enterprise traction, and solid Q1 results. Read why ...

When the mega terminal's first phase is completed in the mid-2030s, it will be able to handle about 50 million passengers ...

Shenghe Resources’ subsidiary, Ganzhou Chenguang Rare Earths New Material Co, has agreed to acquire PEK under a binding ...